Thermo Fisher Scientific Inc. (NYSE:TMO) Shares Sold by Community Trust & Investment Co.

Community Trust & Investment Co. lowered its position in Thermo Fisher Scientific Inc. (NYSE:TMO) by 0.8% in the second quarter, Holdings Channel reports. The fund owned 28,512 shares of the medical research company’s stock after selling 239 shares during the period. Community Trust & Investment Co.’s holdings in Thermo Fisher Scientific were worth $14,876,000 as of its most recent SEC filing.

A number of other institutional investors also recently added to or reduced their stakes in TMO. Moneta Group Investment Advisors LLC lifted its position in shares of Thermo Fisher Scientific by 104,536.8% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 8,355,245 shares of the medical research company’s stock worth $4,601,150,000 after buying an additional 8,347,260 shares during the last quarter. Providence Capital Advisors LLC increased its holdings in shares of Thermo Fisher Scientific by 61,754.7% in the 1st quarter. Providence Capital Advisors LLC now owns 5,842,175 shares of the medical research company’s stock valued at $10,136,000 after acquiring an additional 5,832,730 shares during the period. Norges Bank acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $3,105,677,000. Polen Capital Management LLC acquired a new position in shares of Thermo Fisher Scientific in the 4th quarter valued at $1,208,055,000. Finally, Morgan Stanley increased its holdings in shares of Thermo Fisher Scientific by 17.7% in the 4th quarter. Morgan Stanley now owns 11,730,063 shares of the medical research company’s stock valued at $6,459,629,000 after acquiring an additional 1,764,312 shares during the period. Hedge funds and other institutional investors own 87.06% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. Barclays lifted their target price on shares of Thermo Fisher Scientific from $590.00 to $625.00 and gave the company an “overweight” rating in a report on Thursday, July 27th. Credit Suisse Group raised shares of Thermo Fisher Scientific from a “neutral” rating to an “outperform” rating and set a $620.00 price objective on the stock in a research note on Thursday, July 13th. Royal Bank of Canada boosted their price objective on shares of Thermo Fisher Scientific from $662.00 to $698.00 in a research note on Thursday, July 27th. Robert W. Baird dropped their price objective on shares of Thermo Fisher Scientific from $664.00 to $625.00 and set an “outperform” rating on the stock in a research note on Thursday, July 27th. Finally, StockNews.com raised shares of Thermo Fisher Scientific from a “hold” rating to a “buy” rating in a research note on Friday. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $631.71.

Insider Buying and Selling at Thermo Fisher Scientific

In other news, EVP Gianluca Pettiti sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $557.77, for a total transaction of $1,673,310.00. Following the completion of the transaction, the executive vice president now owns 17,556 shares of the company’s stock, valued at approximately $9,792,210.12. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. In other news, EVP Gianluca Pettiti sold 3,000 shares of the company’s stock in a transaction dated Wednesday, August 30th. The shares were sold at an average price of $557.77, for a total transaction of $1,673,310.00. Following the completion of the transaction, the executive vice president now owns 17,556 shares of the company’s stock, valued at approximately $9,792,210.12. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, CEO Marc N. Casper sold 1,600 shares of the stock in a transaction that occurred on Tuesday, August 8th. The stock was sold at an average price of $550.60, for a total transaction of $880,960.00. Following the sale, the chief executive officer now directly owns 135,330 shares of the company’s stock, valued at approximately $74,512,698. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 28,700 shares of company stock worth $15,799,270. Corporate insiders own 0.32% of the company’s stock.

Thermo Fisher Scientific Price Performance

Shares of Thermo Fisher Scientific stock traded down $3.15 on Tuesday, hitting $504.58. The company’s stock had a trading volume of 324,781 shares, compared to its average volume of 1,493,450. Thermo Fisher Scientific Inc. has a 52-week low of $475.77 and a 52-week high of $609.85. The company has a quick ratio of 1.02, a current ratio of 1.42 and a debt-to-equity ratio of 0.67. The firm has a fifty day moving average price of $540.37 and a 200-day moving average price of $541.53. The company has a market capitalization of $194.74 billion, a P/E ratio of 34.72, a price-to-earnings-growth ratio of 2.43 and a beta of 0.77.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings results on Wednesday, July 26th. The medical research company reported $5.15 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $5.43 by ($0.28). The firm had revenue of $10.69 billion during the quarter, compared to analysts’ expectations of $10.99 billion. Thermo Fisher Scientific had a net margin of 13.14% and a return on equity of 18.59%. Thermo Fisher Scientific’s revenue for the quarter was down 2.6% on a year-over-year basis. During the same quarter last year, the company posted $5.51 earnings per share. On average, equities research analysts expect that Thermo Fisher Scientific Inc. will post 22.37 earnings per share for the current fiscal year.

Thermo Fisher Scientific Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, October 13th. Shareholders of record on Friday, September 15th will be issued a $0.35 dividend. The ex-dividend date of this dividend is Thursday, September 14th. This represents a $1.40 dividend on an annualized basis and a yield of 0.28%. Thermo Fisher Scientific’s dividend payout ratio (DPR) is 9.57%.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the United States and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, clinical next-generation sequencing, bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.